Related Experiment Video
Updated: Jun 16, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Multimodality treatments in locally advanced stage thymomas
Mohammad Hassan1, Diaa Eldin A Seoud
1Department of Oncology, Erfan Hospital, Jeddah, Saudi Arabia.
Hematology/Oncology and Stem Cell Therapy
|February 2, 2010
Summary
Multimodality treatment, including neoadjuvant chemotherapy, surgery, and radiation, improved resectability and survival for advanced thymoma. This approach offers a good long-term outcome for patients with locally advanced unresectable thymic tumors.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Complete surgical resection is the primary goal for thymoma treatment.
- Advanced stage (III and IVA) thymoma often presents unresectable due to local invasion or widespread implants.
- Multimodality treatment is explored for locally advanced, unresectable thymoma.
Purpose of the Study:
- To evaluate the effectiveness and safety of multimodality treatment for advanced stage (III and IVA) thymoma.
- To assess the impact of neoadjuvant chemotherapy on resectability rates.
- To determine long-term outcomes in patients with locally advanced unresectable thymoma.
Main Methods:
- A cohort of patients with newly diagnosed, unresectable malignant thymoma was studied.
- Treatment involved neoadjuvant chemotherapy (cisplatin and etoposide), surgical resection, postoperative radiation, and consolidation chemotherapy.
- Chemotherapy regimens consisted of three courses of cisplatin and etoposide.
Main Results:
- Neoadjuvant chemotherapy achieved a 77% overall response rate (11% complete, 66% partial).
- Surgical resection was performed in 8 of 9 patients, with complete tumor removal in 62.5%.
- At 4 years, 77% of patients were alive and 66.6% were disease-free. Myelosuppression was the main side effect.
Conclusions:
- Multimodality treatment integrating surgery, radiotherapy, and chemotherapy leads to favorable long-term outcomes in advanced thymic tumors.
- Neoadjuvant chemotherapy enhances resectability and improves survival for locally advanced thymoma.
- This combined approach is effective and safe for managing unresectable thymoma.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...